Concepedia

Author

Gareth Shackleton

Sanofi (Mexico)ORCID

Also Known As

G. Shackleton, G.L. Shackleton, Gareth L. Shackleton, Gareth Shackleton

13

Publications

202

Citations

6

H-Index

24

Concepts

All Affiliations

Sanofi (Mexico)The Barbara Ann Karmanos Cancer InstituteWayne State UniversitySanofi (United States)University of Surrey
GS

About

Gareth Shackleton is an author at Sanofi (Mexico) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

169

2

Health Sciences

2

2

140

3

Biochemistry

1

1

19

4

Cell Biology

1

1

13

5

Cellular Physiology

1

1

13

Gareth Shackleton

×

5

Publications

179

Citations

5

H-Index

YearCitations

Antioxidant defenses in the bile duct-ligated rat

Sukhpal Singh, Gareth Shackleton, Eric Ah-Sing,

Gastroenterology

1992

127

High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma

Srinivasu Poondru, Sen-Lin Zhou, James Rake,

Journal of Chromatography B Biomedical Sciences and Applications

2001

19

Diverse Mechanisms of Calcium Mobilization by Peroxisome Proliferators in Rat Hepatocytes

Gareth Shackleton, G. Gordon Gibson, Raj Kumar Sharma,

Toxicology and Applied Pharmacology

1995

13

A Phase I Dose-Escalation Study of SR271425, an Intravenously Dosed Thioxanthone Analog, Administered Weekly in Patients With Refractory Solid Tumors

A. Craig Lockhart, Emiliano Calvo, Anthony W. Tolcher,

American Journal of Clinical Oncology

2009

10

Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies

Priscila Gonçalves, Francine High, Paul E. Juniewicz,

Investigational New Drugs

2008

10

Page 1